| 1. Title: [Etude statistique a propos de 496 utilisatrices). (Monilial vulvovaginitis and oral contraceptives. Statistical study on 496 users)] Vulvo-vaginites moniliasques et contraceptifs oraux. Author: Dugois P; Amblard F; Manent J; De Bignicourt B Source: Semaine des Hopitaux de Paris. 1971 Dec 8;47(59-50):2803-2806. Abstract: Incidence of vaginitis due to Candida albicans confirmed by culture was 46 of 496 (9.3%) French women taking contraceptive pills. The women had used pills for a total of 5198 cycles, in which 1991 were combined lynestrenol-mestranol, 804 were norethynodrel, 525 were ethynodiol and 473 were norethisterone combinations. The study group varied widely in age, economic class, marital status and parity, but no relationship could be found between yeast infection and age, parity, marital status, miscarriages or product used. This 9.3% incidence is about the same as that in healthy women not using pills. The authors thought that virulence was increased in these pill users, although all responded to local treatment without recurrence. Language: French Keywords: CLINICAL RESEARCH | ORAL CONTRACEPTIVES, SIDE EFFECTS | VAGINITIS | VAGINAL DESQUAMATE EFFECTS | ORAL CONTRACEPTIVES, COMBINED | LYNESTRENOL | MESTRANOL | NORETHYNODREL | ETHYNODIOL DIACETATE | NORETHINDRONE | CHLORMADINONE ACETATE | GLUCOSE METABOLISM EFFECTS | SIDE EFFECTS | Research Methodology | Contraceptive Safety | Safety | Public Health | Health | Vaginal Abnormalities | Diseases | Oral Contraceptives | Contraceptive Methods | Contraception | Family Planning | Contraceptive Agents, Progestin | Contraceptive Agents, Female | Contraceptive Agents | Contraceptive Agents, Estrogen | Carbohydrate Metabolic Effects | Metabolic Effects | Physiology | Biology | Treatment Document Number: 711023 |
 |
||
 |
Information & Knowledge for Optimal Health (INFO) Project 111 Market Place Suite 310, Baltimore, MD 21202 Phone: 410-659-6300 Fax: 410-659-6266 Security & Privacy Policy |  |